Logo image of PRX.AS

PROSUS NV (PRX.AS) Stock Fundamental Analysis

Europe - AMS:PRX - NL0013654783 - Common Stock

61.49 EUR
+0.35 (+0.57%)
Last: 10/3/2025, 11:32:14 AM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to PRX. PRX was compared to 12 industry peers in the Broadline Retail industry. PRX has only an average score on both its financial health and profitability. PRX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make PRX a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

PRX had positive earnings in the past year.
In the past year PRX had a positive cash flow from operations.
Each year in the past 5 years PRX has been profitable.
The reported operating cash flow has been mixed in the past 5 years: PRX reported negative operating cash flow in multiple years.
PRX.AS Yearly Net Income VS EBIT VS OCF VS FCFPRX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

The Return On Assets of PRX (17.04%) is better than 91.67% of its industry peers.
PRX has a Return On Equity of 24.23%. This is in the better half of the industry: PRX outperforms 66.67% of its industry peers.
PRX's Return On Invested Capital of 0.21% is on the low side compared to the rest of the industry. PRX is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
ROA 17.04%
ROE 24.23%
ROIC 0.21%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
PRX.AS Yearly ROA, ROE, ROICPRX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1.3 Margins

PRX has a Profit Margin of 200.44%. This is amongst the best in the industry. PRX outperforms 91.67% of its industry peers.
In the last couple of years the Profit Margin of PRX has grown nicely.
PRX has a Operating Margin of 3.05%. This is amonst the worse of the industry: PRX underperforms 83.33% of its industry peers.
PRX's Gross Margin of 42.53% is on the low side compared to the rest of the industry. PRX is outperformed by 66.67% of its industry peers.
In the last couple of years the Gross Margin of PRX has grown nicely.
Industry RankSector Rank
OM 3.05%
PM (TTM) 200.44%
GM 42.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
PRX.AS Yearly Profit, Operating, Gross MarginsPRX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300 400

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PRX is destroying value.
Compared to 1 year ago, PRX has less shares outstanding
PRX has more shares outstanding than it did 5 years ago.
PRX has a better debt/assets ratio than last year.
PRX.AS Yearly Shares OutstandingPRX.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
PRX.AS Yearly Total Debt VS Total AssetsPRX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

PRX has an Altman-Z score of 5.84. This indicates that PRX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of PRX (5.84) is better than 75.00% of its industry peers.
PRX has a debt to FCF ratio of 9.30. This is a negative value and a sign of low solvency as PRX would need 9.30 years to pay back of all of its debts.
With a Debt to FCF ratio value of 9.30, PRX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
PRX has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
PRX's Debt to Equity ratio of 0.30 is fine compared to the rest of the industry. PRX outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Altman-Z 5.84
ROIC/WACC0.03
WACC8.39%
PRX.AS Yearly LT Debt VS Equity VS FCFPRX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B 50B

2.3 Liquidity

PRX has a Current Ratio of 3.54. This indicates that PRX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PRX (3.54) is better than 100.00% of its industry peers.
PRX has a Quick Ratio of 3.50. This indicates that PRX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.50, PRX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.54
Quick Ratio 3.5
PRX.AS Yearly Current Assets VS Current LiabilitesPRX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.26% over the past year.
PRX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.24% yearly.
The Revenue has grown by 12.86% in the past year. This is quite good.
PRX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.13% yearly.
EPS 1Y (TTM)103.26%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%161.96%
Revenue 1Y (TTM)12.86%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%10.17%

3.2 Future

PRX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.60% yearly.
PRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.94% yearly.
EPS Next Y23.15%
EPS Next 2Y18.93%
EPS Next 3Y19.6%
EPS Next 5YN/A
Revenue Next Year22.74%
Revenue Next 2Y18.27%
Revenue Next 3Y16.94%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PRX.AS Yearly Revenue VS EstimatesPRX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
PRX.AS Yearly EPS VS EstimatesPRX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.97, the valuation of PRX can be described as correct.
91.67% of the companies in the same industry are more expensive than PRX, based on the Price/Earnings ratio.
PRX is valuated rather cheaply when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 17.86, which indicates a rather expensive current valuation of PRX.
Based on the Price/Forward Earnings ratio, PRX is valued a bit cheaper than 66.67% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of PRX to the average of the S&P500 Index (23.29), we can say PRX is valued slightly cheaper.
Industry RankSector Rank
PE 13.98
Fwd PE 17.86
PRX.AS Price Earnings VS Forward Price EarningsPRX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

PRX's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. PRX is more expensive than 83.33% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as PRX.
Industry RankSector Rank
P/FCF 97.31
EV/EBITDA 468.34
PRX.AS Per share dataPRX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PRX's earnings are expected to grow with 19.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.6
PEG (5Y)0.81
EPS Next 2Y18.93%
EPS Next 3Y19.6%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.17%, PRX is not a good candidate for dividend investing.
PRX's Dividend Yield is a higher than the industry average which is at 1.14.
With a Dividend Yield of 0.17, PRX pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 0.17%

5.2 History

The dividend of PRX decreases each year by -19.73%.
Dividend Growth(5Y)-19.73%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

PRX pays out 2.17% of its income as dividend. This is a sustainable payout ratio.
DP2.17%
EPS Next 2Y18.93%
EPS Next 3Y19.6%
PRX.AS Yearly Income VS Free CF VS DividendPRX.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
PRX.AS Dividend Payout.PRX.AS Dividend Payout, showing the Payout Ratio.PRX.AS Dividend Payout.PayoutRetained Earnings

PROSUS NV

AMS:PRX (10/3/2025, 11:32:14 AM)

61.49

+0.35 (+0.57%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)06-23 2025-06-23/amc
Earnings (Next)11-24 2025-11-24
Inst Owners64.41%
Inst Owner ChangeN/A
Ins Owners0.88%
Ins Owner ChangeN/A
Market Cap146.28B
Analysts76.52
Price Target59.83 (-2.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.17%
Yearly Dividend0.04
Dividend Growth(5Y)-19.73%
DP2.17%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.03%
PT rev (3m)6.19%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.13%
EPS NY rev (3m)2.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.08%
Revenue NY rev (3m)9.33%
Valuation
Industry RankSector Rank
PE 13.98
Fwd PE 17.86
P/S 27.87
P/FCF 97.31
P/OCF 91.8
P/B 3.37
P/tB 3.47
EV/EBITDA 468.34
EPS(TTM)4.4
EY7.16%
EPS(NY)3.44
Fwd EY5.6%
FCF(TTM)0.63
FCFY1.03%
OCF(TTM)0.67
OCFY1.09%
SpS2.21
BVpS18.26
TBVpS17.7
PEG (NY)0.6
PEG (5Y)0.81
Profitability
Industry RankSector Rank
ROA 17.04%
ROE 24.23%
ROCE 0.28%
ROIC 0.21%
ROICexc 0.3%
ROICexgc 0.31%
OM 3.05%
PM (TTM) 200.44%
GM 42.53%
FCFM 28.64%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
F-Score6
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Debt/EBITDA 45.16
Cap/Depr 72.6%
Cap/Sales 1.72%
Interest Coverage 0.36
Cash Conversion 560.78%
Profit Quality 14.29%
Current Ratio 3.54
Quick Ratio 3.5
Altman-Z 5.84
F-Score6
WACC8.39%
ROIC/WACC0.03
Cap/Depr(3y)83.48%
Cap/Depr(5y)79.69%
Cap/Sales(3y)2.75%
Cap/Sales(5y)2.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.26%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%161.96%
EPS Next Y23.15%
EPS Next 2Y18.93%
EPS Next 3Y19.6%
EPS Next 5YN/A
Revenue 1Y (TTM)12.86%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%10.17%
Revenue Next Year22.74%
Revenue Next 2Y18.27%
Revenue Next 3Y16.94%
Revenue Next 5YN/A
EBIT growth 1Y212.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year328.77%
EBIT Next 3Y95.43%
EBIT Next 5YN/A
FCF growth 1Y181.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y169.5%
OCF growth 3YN/A
OCF growth 5YN/A